PRDM16 是一个紧心肌丰富的转录因子,需要维持左心室紧心肌细胞的身份
Tongbin Wu1, Zhengyu Liang2, Zengming Zhang1
1Department of Medicine (T.W., Z.Z., C.L., Y.G., K.L.P., S.M.E., J.C.), University of California San Diego, La Jolla.
Circulation
|December 17, 2021
概括
通过破坏紧心肌细胞的特异性,导致左心室非紧缩性心肌病 (LVNC). 这项研究揭示了PRDM16在调节LV室生长和成熟中的作用,解释了LVNC中的LV敏感性.
科学领域:
- 心脏病学
- 分子生物学
- 遗传学
背景情况:
- 左心室非紧缩性心肌病 (LVNC) 的特征是过度的和薄壁,主要影响左心室.
- 由于缺乏准确的动物模型,对LVNC的LV扩张和功能障碍的机制知之甚少.
- 与PRDM16突变存在遗传联系,但其在LVNC病变中的确切作用尚不清楚.
研究的目的:
- 调查PRDM16在左心室非紧缩性心肌病 (LVNC) 的发病作用.
- 阐明PRDM16缺乏导致LVNC的分子机制.
- 开发一个精确复制人类LVNC表型的小鼠模型.
主要方法:
- 产生心肌细胞特异性Prdm16敲除小鼠以研究心脏表型.
- 使用RNA测序和ChIP测序来识别心肌细胞中的PRDM16转录标.
- 使用单细胞RNA测序和空间转录组学来分析心肌细胞身份.
主要成果:
- 心肌细胞特异性Prdm16切除导致LV特异性扩张,功能障碍和双心室非紧缩,反映了人类LVNC.
- PRDM16作为转录因子,促进心肌基因的紧和抑制心肌基因在LV.
- 由于与Tbx5和Hand1的合作,PRDM16的丢失导致LV心肌细胞转录转向状或神经元特征.
结论:
- 紧心肌细胞特征的破坏是LVNC病变的一个关键因素.
- 在室内生长和成熟的LV受限转录程序中,PRDM16起着至关重要的作用.
- 这项研究为某些 LVNC 病例的左心室敏感性提供了机制性的解释.
更多相关视频
10:05Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
8.8K
08:52Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
Published on: March 10, 2016
7.9K
相关概念视频
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
87
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
87
01:30Cardiomyopathy II: Dilated Cardiomyopathy
60
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
02:23Master Transcription Regulators
7.2K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
86
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
01:25Cardiomyopathy I: Introduction and Classification
115
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
115